These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 10502395)

  • 1. Vascular endothelial (VE)-cadherin: only an intercellular glue?
    Dejana E; Bazzoni G; Lampugnani MG
    Exp Cell Res; 1999 Oct; 252(1):13-9. PubMed ID: 10502395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial cadherins and tumor angiogenesis.
    Cavallaro U; Liebner S; Dejana E
    Exp Cell Res; 2006 Mar; 312(5):659-67. PubMed ID: 16256984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of endothelial barrier function during normal angiogenesis requires homotypic VE-cadherin adhesion.
    DeFouw LM; DeFouw DO
    Tissue Cell; 2000 Jun; 32(3):238-42. PubMed ID: 11037794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.
    Liao F; Doody JF; Overholser J; Finnerty B; Bassi R; Wu Y; Dejana E; Kussie P; Bohlen P; Hicklin DJ
    Cancer Res; 2002 May; 62(9):2567-75. PubMed ID: 11980651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular organization of endothelial junctions and their functional role in vascular morphogenesis and permeability.
    Dejana E; Lampugnani MG; Martinez-Estrada O; Bazzoni G
    Int J Dev Biol; 2000; 44(6):743-8. PubMed ID: 11061439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cdc42 regulates adherens junction stability and endothelial permeability by inducing alpha-catenin interaction with the vascular endothelial cadherin complex.
    Broman MT; Kouklis P; Gao X; Ramchandran R; Neamu RF; Minshall RD; Malik AB
    Circ Res; 2006 Jan; 98(1):73-80. PubMed ID: 16322481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenesis: the VE-cadherin switch.
    Wallez Y; Vilgrain I; Huber P
    Trends Cardiovasc Med; 2006 Feb; 16(2):55-9. PubMed ID: 16473763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VE-cadherin increases the half-life of VEGF receptor 2.
    Calera MR; Venkatakrishnan A; Kazlauskas A
    Exp Cell Res; 2004 Oct; 300(1):248-56. PubMed ID: 15383331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of cadherins in the transendothelial migration of melanoma cells in culture.
    Sandig M; Voura EB; Kalnins VI; Siu CH
    Cell Motil Cytoskeleton; 1997; 38(4):351-64. PubMed ID: 9415377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation of endothelial cell monolayer permeability by hyperthermia but not tumor necrosis factor: evidence for disruption of vascular integrity via VE-cadherin down-regulation.
    Friedl J; Turner E; Alexander HR
    Int J Oncol; 2003 Sep; 23(3):611-6. PubMed ID: 12888895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breaking the VE-cadherin bonds.
    Gavard J
    FEBS Lett; 2009 Jan; 583(1):1-6. PubMed ID: 19059243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tumour necrosis factor-alpha induced vascular permeability is associated with a reduction of VE-cadherin expression.
    Hofmann S; Grasberger H; Jung P; Bidlingmaier M; Vlotides J; Janssen OE; Landgraf R
    Eur J Med Res; 2002 Apr; 7(4):171-6. PubMed ID: 12010652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148.
    Grazia Lampugnani M; Zanetti A; Corada M; Takahashi T; Balconi G; Breviario F; Orsenigo F; Cattelino A; Kemler R; Daniel TO; Dejana E
    J Cell Biol; 2003 May; 161(4):793-804. PubMed ID: 12771128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial barrier stabilization by a cyclic tandem peptide targeting VE-cadherin transinteraction in vitro and in vivo.
    Heupel WM; Efthymiadis A; Schlegel N; Müller T; Baumer Y; Baumgartner W; Drenckhahn D; Waschke J
    J Cell Sci; 2009 May; 122(Pt 10):1616-25. PubMed ID: 19420236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond vessels: occurrence and regional clustering of vascular endothelial (VE-)cadherin-containing junctions in non-endothelial cells.
    Boda-Heggemann J; Régnier-Vigouroux A; Franke WW
    Cell Tissue Res; 2009 Jan; 335(1):49-65. PubMed ID: 19002500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACTH depletion represses vascular endothelial-cadherin transcription in mouse adrenal endothelium in vivo.
    Huber P; Mallet C; Faure E; Rampon C; Prandini MH; Féraud O; Bouillot S; Vilgrain I
    J Mol Endocrinol; 2005 Feb; 34(1):127-37. PubMed ID: 15691883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes.
    Navaratna D; McGuire PG; Menicucci G; Das A
    Diabetes; 2007 Sep; 56(9):2380-7. PubMed ID: 17536065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac ischemia activates vascular endothelial cadherin promoter in both preexisting vascular cells and bone marrow cells involved in neovascularization.
    Kogata N; Arai Y; Pearson JT; Hashimoto K; Hidaka K; Koyama T; Somekawa S; Nakaoka Y; Ogawa M; Adams RH; Okada M; Mochizuki N
    Circ Res; 2006 Apr; 98(7):897-904. PubMed ID: 16543497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing intercellular interactions between vascular endothelial cadherin pairs at single-molecule resolution and in living cells.
    Panorchan P; George JP; Wirtz D
    J Mol Biol; 2006 May; 358(3):665-74. PubMed ID: 16540120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired VE-cadherin/beta-catenin expression mediates endothelial cell degeneration in dilated cardiomyopathy.
    Schäfer R; Abraham D; Paulus P; Blumer R; Grimm M; Wojta J; Aharinejad S
    Circulation; 2003 Sep; 108(13):1585-91. PubMed ID: 12963640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.